Two weeks after the European Medicines Agency first assured EU member states it had found no link between the Oxford/AstraZeneca vaccine and earlier reports of rare blood clots, a growing number of countries have announced new restrictions on the use of the jab.
两周前，欧洲药品管理局(European Medicines Agency)首次向欧盟成员国保证，它没有发现牛津/阿斯利康(Oxford/AstraZeneca)疫苗与早些时候报告的罕见血栓病例存在联系，而现在已有越来越多的国家宣布限制接种该疫苗。
您已阅读4%（386字），剩余96%（9573字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。